White matter alterations within the brain are associated with cognitive impairment among individuals with and without major ...

The heart and brain are in constant communication. This communication is vital for the health of both organs. Here's how it ...

From 2017 to 2021, pediatric depression and anxiety rates increased by 55.6% and 31.1%, respectively. Rates were higher ...

Nelivaptan (NB-415, SSR-149415) is under development for the treatment of depression including major depressive disorder (MDD). The drug candidate targets vasopressin receptor 1B ( (V1bR). It is ...

Depression, sometimes called major depressive disorder, can hurt your ability to think through even simple daily tasks. Doctors call this decline in thinking skills "cognitive impairment." ...

Vagus nerve stimulation therapy improved the symptoms of treatment-resistant depression for nearly 500 participants in a ...

P rogress in addressing mental health is notoriously slow and mostly incremental. Breakthrough treatments tend to be rare, ...

Neumora Therapeutics to release phase 3 data on Navacaprant for MDD treatment in 2024. Check out NMRA's catalysts that might ...

A groundbreaking clinical trial has revealed that nerve-stimulating therapy can bring significant improvements to people with ...

InterRhythmic care may help improve depressive and anxiety symptoms, interpersonal problems, and social function in patients with major depressive disorder.

People with severe, treatment-resistant depression who received a nerve-stimulating therapy showed significant improvement in ...